T-Cell Engager: From Discovery Hurdles to Next-Gen Solutions

Addressing TCE Discovery Challenges with Expert Insights

T-cell engagers (TCEs) are revolutionizing cancer immunotherapy, but their discovery remains complex, requiring extensive expertise across molecular engineering, protein production, analytical characterization, and preclinical evaluation.

This white paper outlines practical strategies throughout the TCE discovery stages and introduces next-gen solutions to overcome evolving challenges, setting the foundation for preclinical success.

Download the white paper to discover:

• Innovative platforms across key stages of TCE discovery
• Proven approaches for navigating structural complexity, CRS risks, and tumor heterogeneity
• Forward-looking perspectives on pairing TCEs with immune-modulatory domains or checkpoint inhibitors
• Real-world case studies showcasing high-purity production and fit-for-purpose in vitro/in vivo studies